CSAM Acquires Optima - Further Boosts eHealth Public Safety Offering

CSAMCSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from Chicago, USA-based R1 RCM.

With the acquisition of Optima Corporation, CSAM Health Group will bring market-leading Optima products, impressive customer base and skilled teams in Auckland, New Zealand, Chicago, US, and Reading, UK, into the CSAM family.

"Optima's well-established "Predict" and "Live" product solutions expand CSAM Health Group's reach significantly with marquee-level customers within the Public Safety arena already established in New Zealand, Australia, the US, Canada, UK and several other countries, including Norway and Denmark, “confirms Sverre Flatby, CEO, CSAM Health Group.

"In addition, adding valuable and proven software to further boost our rescue services will not only benefit all our clients but also increase CSAM's rapidly growing market presence into new, exciting territories."

The new products will be added to CSAM's growing bouquet of public safety solutions within the eHealth arena, adding Optima's enhanced solutions for optimization of the rescue services through prediction and analytical software and services.

"Our ambition is to be the preferred option for public safety agencies who want advanced operational and planning capabilities that go beyond guesswork, continues Flatby. Combined with the acquisition of Carmenta Public Health in February, Optima brings us one step closer to solidifying our goal of being the market-leading provider of niche eHealth solutions within the public safety domain."

For further information, please visit:
http://www.csamhealth.com

About Optima

Optima provides decision support and data visualisation software and services, enabling more informed strategic and operational planning while supporting real-time critical analysis and decisions.
  • Optima Predict enables concise and accurate analysis, modelling and simulation for an endless range of "what if?" scenarios.
  • Optima Live offers a dynamic, real-time view of emergency resources to support dispatch in making critical decisions.

Acquisition details

  • Signing took place June 30th. Closing of the acquisition will take place June 30, 2021
  • RSM and Haavind have acted as advisors on Financial and Legal matters for CSAM Health Group
  • The Optima products reported sales of 2.8 MUSD in 2020, with a reported EBITDA-margin of -8%
  • The agreed transaction price is 2.75 MUSD and will be settled in cash

CSAM's growing bouquet of benchmark eHealth solutions

CSAM's strategy is to gather the best e-health software services solutions on the market into one unique family to provide a complete portfolio of benchmark. CSAM is harnessing best-of-breed technology and solutions to empower its customers to do what they do best.

About CSAM

CSAM has established itself as a leading Nordic niche player in the specialised eHealth market with a unique blend of best-in-class innovative technology, and outstanding human skills. The company's diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. CSAM's commercial headquarters are located in Oslo, Norway. In addition, CSAM has 17 local offices in 10 countries in Europe, Asia and North America.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Researchers Use AI to Predict Cancer Ris…

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...